Dipl. Biochem. Stephan Mattecka - Project manager of the adsorber technology - has accompanied the development project since 2010, initially as a research project at the Charité - University Medicine Berlin. He wrote his diploma thesis at the Department of Nephrology and Medical Intensive Care (AG Sheriff). He is co-inventor in a patent application.
The Pentracor GmbH was founded in 2010. Since November 2014 Pentracor GmbH is responsible for the production and distribution of CRP adsorbers according to EN ISO 13485.
The central functions at Pentracor are represented by the following persons:
Dr. rer. nat. Ahmed Sheriff - Founder and Managing Director - is a biochemist with several years of research work in the field of immunology of inflammatory diseases at the Institute of Clinical Immunology at the University of Erlangen. Previously, Dr. Sheriff gained business experience in the biotechnological company Genethor GmbH, which he founded. From 2007 - 2008, Dr. Sheriff was Managing Director of the European Federation of Immunological Societies. From 2007 to 2010 he was Managing Director of the German Society of Immunology. He is inventor or co-inventor on 26 patents/applications.
Dipl.-Ing. (FH) Biotechnology Birgit Vogt - Founder and authorised signatory, scientific director - has many years of experience in applied medical research (Fraunhofer Institute for Toxicology and Aerosol Research, Hanover; Heinrich-Pette-Institute, Hamburg, Charité - University Medicine Berlin) as well as in setting up companies. At Genethor GmbH, Ms Vogt was responsible for the organisation of experimental research. Ms Vogt has a teaching position at the Beuth Hochschule Berlin. She is inventor or co-inventor on 12 patents/applications.
Dipl. Business Economist Rainer Mohr – CFO – hat nach seinem Studium der Betriebswirtschaftslehre zunächst ca. 10 Jahre in Führungspositionen im kaufmännischen und finanziellen Bereich namhafter Unternehmen Erfahrungen gesammelt. Es folgten ca. 15 Jahre als kaufmännischer Geschäftsführer verschiedener GmbHs mit Umsatzvolumina von 200 – 500 Mio. Euro. Dort etablierte er erfolgreich die kaufmännischen und finanziellen Strukturen und trug dank seinem technischen Verständnis auch die Verantwortung für die strategischen Entwicklungen dieser Unternehmen. Seit 2012 ist Herr Mohr als selbstständiger Interim-Manager tätig. Er ist spezialisiert auf die strategische Entwicklung von Unternehmen, effektive kaufmännische und finanzielle Strukturen sowie jede Art von notwendigen Veränderungsprozessen. Neben der verantwortlichen Übernahme von Geschäftsführungen von kleineren Unternehmen in der Entwicklungsphase, beschäftigt er sich sowohl mit Coaching und Sparring-Aufgaben im Management-Bereich als auch mit der Zusammenführung wirksamer Teamstrukturen.
Holger Zorn – Sales and Marketing – perfusionist and medical journalist with 25 years of experience in the application, development, marketing and promotion of extracorporeal technologies in clinical, trade and industry settings.
Dr. vet. med. Burghard Thiesen - Safety Officer for Medical Devices (SMPG) and Head of Clinical Research - is a veterinarian. He did his doctoral thesis at the Schering AG in the field of contrast media pharmacology. From 1985 - 1989 he did scientific work on surface structures of bacteria at the Institute of Microbiology and Animal Hygienics at the Department of Veterinary Medicine, Free University Berlin and on immunology of bacterial infections at the Max Planck Institute of Molecular Genetics in Berlin (1989 - 1992). At the Charité - University Medicine Berlin he worked in the research project "Nanotechnology in Medicine" from 2002 - 2007. At MagForce AG, he was responsible for risk management and clinical trial management in conformity assessment procedures of various medical devices (class II and III) for the therapy of tumor diseases (2007 - 2012).
Dr.-Ing. Gunnar Janelt - Head of Production - is a biotechnologist. From 1999 - 2005, he was head of production of immune adsorbers at Affina Immuntechnik GmbH, later Fresenius Medical Care Affina GmbH, where he established production and developed and established processes. He also helped to design and establish the quality management system. From 2006 - 2011 he worked at the Charité - University Medicine Berlin, Department of Nephrology and Medical Intensive Care in the research project "Liver dialysis" for the development and establishment of a liver support system based on albumin and microparticles. He has accompanied the research project "Development of a CRP adsorber" for the therapy of acute myocardial infarction from the very beginning. He is co-inventor on 3 patent applications.
Dipl.-Ing. (FH) Biotechnology Gülcan Yapici - QMB and Head of the Department of Regulatory Affairs - has accompanied the development project since its inception as a research project at the Charité - Universitätsmedizin Berlin. She wrote her diploma thesis in the Department of Trauma and Reconstructive Surgery, Laboratory for Gene Therapy and Inflammation.
Dipl. BA (FH) Daniel Kaiser - heads the finance department - brings 27 years of experience in supply and operations management from a retail group operating throughout Europe. His expertise includes the management of logistics and accounts payable units, as well as many years of management training.
Vet. med. Christopher Bock - Head of Market Development, Deputy SMPG, Senior Medical Device Advisor, Clinical Research Associate - is a veterinarian and has accompanied the adsorber project since its initiation as a research project at Charité - University Medicine Berlin (2009).